Psych News Alert | schizophrenia

FDA Announces Elimination of Clozapine REMS

Feb 25, 2025 12:00:00 AM

LAI Antipsychotics Associated With Diminishing Risk of Relapse but Risk Remains High

Feb 20, 2025 12:00:00 AM

Study Finds Clozapine Is Most Effective Option for Preventing Second Psychosis Relapse

Jan 24, 2025 12:00:00 AM

New Schizophrenia Drug Shows Marked Effect on Cognitive Deficits

Dec 11, 2024 12:00:00 AM

FDA Panel Votes 14-1 Against Clozapine REMS

Nov 20, 2024 12:00:00 AM

For Coordinated Specialty Care, Fidelity to Program Components Matters

Nov 19, 2024 12:00:00 AM